Research targets lysosomal function restoration for neurodegeneration

The Scottish Medicines Consortium (SMC) has approved bimekizumab for adults with active moderate to severe hidradenitis suppurativa (HS) […]

Approval extends ustekinumab’s use to younger patients

Collaboration introduces automation to enhance efficiency

GMP certification enables 4basebio to supply DNA for clinical trials

Advancing care for stage 3 or 4 Hodgkin lymphoma patients

Collaboration expands AI-based risk profiling tools

New therapy developed to repair GJB2 R75W mutation

Janssen drug combination extends life expectancy during trial